Search by Drug Name or NDC

    NDC 62135-0713-41 CLEMASTINE FUMARATE 0.67 mg/5mL Details

    CLEMASTINE FUMARATE 0.67 mg/5mL

    CLEMASTINE FUMARATE is a ORAL SYRUP in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Chartwell RX, LLC. The primary component is CLEMASTINE FUMARATE.

    Product Information

    NDC 62135-0713
    Product ID 62135-713_ffe63870-181f-e007-e053-6294a90a074e
    Associated GPIs
    GCN Sequence Number 011654
    GCN Sequence Number Description clemastine fumarate SYRUP 0.5 MG/5ML ORAL
    HIC3 Z2P
    HIC3 Description ANTIHISTAMINES - 1ST GENERATION
    GCN 46990
    HICL Sequence Number 004512
    HICL Sequence Number Description CLEMASTINE FUMARATE
    Brand/Generic Generic
    Proprietary Name CLEMASTINE FUMARATE
    Proprietary Name Suffix n/a
    Non-Proprietary Name CLEMASTINE FUMARATE
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form SYRUP
    Route ORAL
    Active Ingredient Strength 0.67
    Active Ingredient Units mg/5mL
    Substance Name CLEMASTINE FUMARATE
    Labeler Name Chartwell RX, LLC
    Pharmaceutical Class n/a
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA074884
    Listing Certified Through 2024-12-31

    Package

    NDC 62135-0713-41 (62135071341)

    NDC Package Code 62135-713-41
    Billing NDC 62135071341
    Package 120 mL in 1 BOTTLE (62135-713-41)
    Marketing Start Date 2023-07-07
    NDC Exclude Flag N
    Pricing Information N/A